Transvenous Lead Extraction without Procedure-Related Deaths in 1000 Consecutive Patients: A Single-Center Experience.


Journal

Vascular health and risk management
ISSN: 1178-2048
Titre abrégé: Vasc Health Risk Manag
Pays: New Zealand
ID NLM: 101273479

Informations de publication

Date de publication:
2021
Historique:
received: 30 04 2021
accepted: 17 06 2021
entrez: 13 8 2021
pubmed: 14 8 2021
medline: 25 12 2021
Statut: epublish

Résumé

Transvenous lead extraction (TLE) is now a first-line technique for the treatment of complications related to cardiac implantable electronic devices. The aim of the study was to demonstrate that it is possible to safely perform difficult TLE procedures with a maximum reduction of peri-procedural major complications. A total of 1000 consecutive patients undergoing TLE in a single high-volume center from 2016 to 2019 were studied. All procedures were performed in a hybrid room or operating room by a specialized TLE team. TLE was performed under general anesthesia and monitored by transesophageal echocardiography, and the operating room was suitably equipped for immediate surgical intervention. The effectiveness and safety of the procedures were assessed, with particular emphasis on major complications. In all, 1952 leads with the mean implant duration of 111.7 ± 77.6 months had been extracted. Complete procedural success of patients was achieved in 95.9% and clinical success in 99.1%. Major complications, predominantly cardiac tamponade (63.3%), occurred in 22 patients (2.2%). Rapid diagnosis and immediate intervention were the key to a 100% survival in patients with this complication. Performing procedures in a hybrid operating room under general anesthesia in the presence of a cardiac surgeon and with the use of transesophageal echocardiography significantly improves the safety of transvenous lead extraction.

Sections du résumé

BACKGROUND BACKGROUND
Transvenous lead extraction (TLE) is now a first-line technique for the treatment of complications related to cardiac implantable electronic devices. The aim of the study was to demonstrate that it is possible to safely perform difficult TLE procedures with a maximum reduction of peri-procedural major complications.
METHODS METHODS
A total of 1000 consecutive patients undergoing TLE in a single high-volume center from 2016 to 2019 were studied. All procedures were performed in a hybrid room or operating room by a specialized TLE team. TLE was performed under general anesthesia and monitored by transesophageal echocardiography, and the operating room was suitably equipped for immediate surgical intervention. The effectiveness and safety of the procedures were assessed, with particular emphasis on major complications.
RESULTS RESULTS
In all, 1952 leads with the mean implant duration of 111.7 ± 77.6 months had been extracted. Complete procedural success of patients was achieved in 95.9% and clinical success in 99.1%. Major complications, predominantly cardiac tamponade (63.3%), occurred in 22 patients (2.2%). Rapid diagnosis and immediate intervention were the key to a 100% survival in patients with this complication.
CONCLUSION CONCLUSIONS
Performing procedures in a hybrid operating room under general anesthesia in the presence of a cardiac surgeon and with the use of transesophageal echocardiography significantly improves the safety of transvenous lead extraction.

Identifiants

pubmed: 34385818
doi: 10.2147/VHRM.S318205
pii: 318205
pmc: PMC8352641
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

445-459

Informations de copyright

© 2021 Stefańczyk et al.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest in this work.

Références

Circ Arrhythm Electrophysiol. 2018 Feb;11(2):e004768
pubmed: 29453324
J Clin Med. 2020 Jan 28;9(2):
pubmed: 32013032
Heart Rhythm. 2017 Dec;14(12):e503-e551
pubmed: 28919379
Heart Vessels. 2020 Jun;35(6):825-834
pubmed: 31786644
Europace. 2014 Sep;16(9):1350-5
pubmed: 24554523
Europace. 2018 Jul 1;20(7):1217
pubmed: 29566158
Biomed Res Int. 2018 Dec 18;2018:8796704
pubmed: 30662917
Heart Rhythm. 2015 Jun;12(6):1216-20
pubmed: 25998138
Pacing Clin Electrophysiol. 1999 Sep;22(9):1348-57
pubmed: 10527016
J Am Coll Cardiol. 1999 May;33(6):1671-6
pubmed: 10334441
Circ Arrhythm Electrophysiol. 2016 Sep;9(9):
pubmed: 27625167
Pacing Clin Electrophysiol. 2019 Jul;42(7):1006-1017
pubmed: 31046136
Europace. 2020 Sep 1;22(9):1401-1408
pubmed: 32681177
Circ Arrhythm Electrophysiol. 2012 Apr;5(2):252-7
pubmed: 22362891
Europace. 2009 May;11(5):612-7
pubmed: 19329797
J Clin Med. 2020 May 08;9(5):
pubmed: 32397115
Heart Rhythm. 2009 Jul;6(7):1085-104
pubmed: 19560098
Europace. 2012 Jan;14(1):124-34
pubmed: 22167387
Europace. 2019 Jul 1;21(7):1096-1105
pubmed: 31505593
Pacing Clin Electrophysiol. 2020 Apr;43(4):382-387
pubmed: 32144936
Heart Lung Circ. 2017 Mar;26(3):240-245
pubmed: 27614558
Eur Heart J. 2008 Dec;29(23):2886-93
pubmed: 18948356
JACC Clin Electrophysiol. 2018 Feb;4(2):212-220
pubmed: 29749940
Pacing Clin Electrophysiol. 2015 Nov;38(11):1297-303
pubmed: 26256667
Europace. 2018 Aug 1;20(8):1324-1333
pubmed: 29016781
J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):668-73
pubmed: 24850500
Heart Rhythm. 2017 Dec;14(12):1807-1811
pubmed: 28842225
Kardiol Pol. 2020 Dec 23;78(12):1206-1214
pubmed: 33078921
Europace. 2019 May 1;21(5):771-780
pubmed: 30590520
Pacing Clin Electrophysiol. 2019 Oct;42(10):1355-1364
pubmed: 31433064
J Am Coll Cardiol. 2010 Feb 9;55(6):579-86
pubmed: 20152562
Pacing Clin Electrophysiol. 2015 Dec;38(12):1439-47
pubmed: 26293652
Eur Heart J. 2017 Oct 21;38(40):2995-3005
pubmed: 28369414
JACC Clin Electrophysiol. 2017 Jan;3(1):1-9
pubmed: 29759687
Europace. 2020 Nov 1;22(11):1743-1753
pubmed: 33175984
Pacing Clin Electrophysiol. 1990 Dec;13(12 Pt 2):1871-5
pubmed: 1704557
Clin Physiol Funct Imaging. 2021 Jan;41(1):25-41
pubmed: 32949059
Europace. 2020 Jul 1;22(7):1103-1110
pubmed: 32447388
Pacing Clin Electrophysiol. 2019 Jul;42(7):989-997
pubmed: 30997679
Expert Rev Cardiovasc Ther. 2013 May;11(5):607-16
pubmed: 23621142
Echocardiography. 2020 Apr;37(4):601-611
pubmed: 32154950
Cardiovasc Diagn Ther. 2021 Apr;11(2):394-410
pubmed: 33968618
J Arrhythm. 2020 Feb 14;36(2):343-350
pubmed: 32256885
Heart Rhythm. 2014 May;11(5):799-805
pubmed: 24444444

Auteurs

Paweł Stefańczyk (P)

Department of Cardiology, The Pope John Paul II Province Hospital of Zamość, Zamość, Poland.

Dorota Nowosielecka (D)

Department of Cardiology, The Pope John Paul II Province Hospital of Zamość, Zamość, Poland.

Łukasz Tułecki (Ł)

Department of Cardiac Surgery, The Pope John Paul II Province Hospital of Zamość, Zamość, Poland.

Konrad Tomków (K)

Department of Cardiac Surgery, The Pope John Paul II Province Hospital of Zamość, Zamość, Poland.

Anna Polewczyk (A)

Department of Physiology, Pathophysiology, and Clinical Immunology, Collegium Medicum of Jan Kochanowski University, Kielce, Poland.
Department of Cardiac Surgery, Świętokrzyskie Cardiology Center, Kielce, Poland.

Wojciech Jacheć (W)

Silesian Medical University, 2nd Department of Cardiology, Zabrze, Poland.

Andrzej Kleinrok (A)

Department of Cardiology, The Pope John Paul II Province Hospital of Zamość, Zamość, Poland.
Medical College, Department of Physiotherapy, University of Information Technology and Management, Rzeszów, Poland.

Wojciech Borzęcki (W)

Department of Cardiology, The Pope John Paul II Province Hospital of Zamość, Zamość, Poland.

Andrzej Kutarski (A)

Department of Cardiology, Medical University, Lublin, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH